LIBOGENE is in the business of cancer molecular diagnosis. The company has established an internationally certified CAP laboratory, and is building a tumor mutant gene databank. LIBOGENE has successfully developed many targeted cancer treatment testing panels and identified novel indigenous tumor resistant gene mutations which can be used as important diagnostic biomarkers.
If you have any questions about our products and services, please input the following details, we will contact you as soon as possible to answer your questions.

繁中  |  简中  |  ENG


Global authorities on cancer

Libogene collaborated with global authorities on cancer to provide you with the most complete testing experience

Pathology accreditation

The world’s highest standard of pathology accreditation.

CAP accreditation

The first company in the world to received CAP accreditation.

The first company

The first company in the world to extend the use of second generation sequencing from research purposes to cancer testing.

International clinical trial

International clinical trial recognition study.

Thermo Fisher-certified

The world’s first Thermo Fisher Scientific-certified Ion Torrent service provider.